Literature DB >> 427747

Comparison of cytotoxic effect and cellular uptake of 1-beta-D-arabinofuranosylcytosine and its N4-acyl derivatives, using cultured KB cells.

T Tsuruo, H Iida, S Tsukagoshi, Y Sakurai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427747

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.

Authors:  T Tsuruo; T Matsuzaki; M Matsushita; H Saito; T Yokokura
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  A benzophenazine derivative, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxy-benzo[a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors.

Authors:  T Tsuruo; M Naito; R Takamori; S Tsukahara; J Yamabe-Mitsuhashi; A Yamazaki; T Oh-hara; Y Sudo; S Nakaike; T Yamagishi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.

Authors:  R Ohno; K Kimura; K Ota; Y Miura; A Hoshino; K Hattori; M Hirano; M Ito; T Maekawa; T Nakamura
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

4.  Intracellular activation and cytotoxic action of RS-1541 against cultured human tumor cells.

Authors:  T Takatori; T Koizumi; T Tokui; Y Mitsuhashi; A Shiraishi; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Biological effects of tolytoxin (6-hydroxy-7-O-methyl-scytophycin b), a potent bioactive metabolite from cyanobacteria.

Authors:  G M Patterson; S Carmeli
Journal:  Arch Microbiol       Date:  1992       Impact factor: 2.552

6.  Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil.

Authors:  T Tsuruo; H Iida; K Naganuma; S Tsukagoshi; Y Sakurai
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.